| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |